Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset. However, a recent meta-analysis of antitoxin efficacy in human botulism cases over the past c...

Descripción completa

Detalles Bibliográficos
Autores principales: Torgeman, Amram, Schwartz, Arieh, Diamant, Eran, Baruchi, Tzadok, Dor, Eyal, Ben David, Alon, Pass, Avi, Barnea, Ada, Tal, Arnon, Rosner, Amir, Rosen, Osnat, Zichel, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177009/
https://www.ncbi.nlm.nih.gov/pubmed/30115749
http://dx.doi.org/10.1242/dmm.035089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177009/
https://www.ncbi.nlm.nih.gov/pubmed/30115749
http://dx.doi.org/10.1242/dmm.035089

Ejemplares similares